Officially identified the target receptor for the treatment of neuroblastoma
the researchers say they have identified a type of receptor called protein-tyrosine z phosphatase, or ptprz as a potential drug target for patients with glioblastoma.
the researchers say they have identified a type of receptor called protein-tyrosine z phosphatase, or ptprz as a potential drug target for patients with glioblastoma.
a new drug made from antibodies on shark estimated to bring many medical values is receiving the attention of many people.